Canadian Cardiovascular Society Awarded $1.4M to Continue Important National Study of COVID-19 and mRNA Vaccines
June 7, 2024
New funding from the Public Health Agency of Canada (PHAC) will enable top Canadian cardiology...
CCS News COVID-19 MYCOVACC
Introducing CCS’s NEW Cardiorenal Pocket Guide
June 2, 2023
The Cardiorenal Risk Reduction in Adults Pocket Guide is now here! Pocket Guides are our most...
Cardiorenal Guidelines Pocket Guides
Two classes of glucose-lowering drugs reduce risk of heart failure, kidney complications and death – even in patients without type 2 diabetes
September 30, 2022
New Cardiorenal Protection Guideline urges use of GLP-1RA and SGLT2i drugs to save lives; as many as...
Cardiorenal Guidelines